Controlled clinical trial on the efficacy and safety of oral sulodexide in patients with peripheral occlusive arterial disease

References

• Aburahma A. F., Woodruff B. A. Effects and limitations of pentoxifylline therapy in various stages of peripheral vacular disease of lower extremity. Am. J. Surg. 1990; 160: 266, 2701. Aburahma A. F., Woodruff B. A. Effects and limitations of pentoxifylline therapy in various stages of peripheral vacular disease of lower extremity. Am. J. Surg. 1990; 160: 266, 270
   PubMed Web of Science ®Google Scholar
• Agrati A. M., Mauro M., Savasta C., Palmieri G. C., Palazzini E. A double-blind, crossover, placebo-controlled study of the pro-fibrinolytic and anti-thrombotic effects of oral sulodexide. Adv. Ther. 1992; 9: 147, 1552. Agrati A. M., Mauro M., Savasta C., Palmieri G. C., Palazzini E. A double-blind, crossover, placebo-controlled study of the pro-fibrinolytic and anti-thrombotic effects of oral sulodexide. Adv. Ther. 1992; 9: 147, 155
   Web of Science ®Google Scholar
• Borreani B., Brizio L., Cianfanelli G., Colotto P., Pastorelli M., Zepponi E. Valutazione dell'attività del sulodexide nell'arteriopatia cronica periferica sclero-ateromatosa. Gazz. Med. It. -Arch. Sci. Med. 1993; 152: 21, 243. Borreani B., Brizio L., Cianfanelli G., Colotto P., Pastorelli M., Zepponi E. Valutazione dell'attività del sulodexide nell'arteriopatia cronica periferica sclero-ateromatosa. Gazz. Med. It. -Arch. Sci. Med. 1993; 152: 21, 24
   Google Scholar
• Buzzi A., Canaveris G., Cibeira J. B., Adema M., Franchella J. E. Modifications of muscle blood flow produced by pentoxifylline in peripheral arterial occlusive disease. Pharmatherapeutica 1976; 1: 234, 2384. Buzzi A., Canaveris G., Cibeira J. B., Adema M., Franchella J. E. Modifications of muscle blood flow produced by pentoxifylline in peripheral arterial occlusive disease. Pharmatherapeutica 1976; 1: 234, 238
   Google Scholar
• Calabro A., Rossi A., Baiocchi M. R., Coscetti G., Fellin R., Crepaldi G. Effetto del sulodexide su alcuni parametri emoreologici in un gruppo di pazienti con vasculopatia arteriopatica periferica. Ric. Clin. Lab. 1985; 15: 455, 4635. Calabro A., Rossi A., Baiocchi M. R., Coscetti G., Fellin R., Crepaldi G. Effetto del sulodexide su alcuni parametri emoreologici in un gruppo di pazienti con vasculopatia arteriopatica periferica. Ric. Clin. Lab. 1985; 15: 455, 463
   PubMedGoogle Scholar
• Caramelli L., Mirchioni R., Carini A. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations. Eur. Rev. Med. Pharmacol. Sci. 1988; X: 55–586. Caramelli L., Mirchioni R., Carini A. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations. Eur. Rev. Med. Pharmacol. Sci. 1988; X: 55–58
   Google Scholar
• Catania G., Salanitri T. Pharmacological treatment of intermittent claudication: double blind controlled study of sulodexide vs placebo. Eur. Rev. Med. Pharmacol. Sci. 1992; XIV: 149–1577. Catania G., Salanitri T. Pharmacological treatment of intermittent claudication: double blind controlled study of sulodexide vs placebo. Eur. Rev. Med. Pharmacol. Sci. 1992; XIV: 149–157
   Google Scholar
• Castelluccio A., Bologna E. Effect of sulodexide on blood viscosity in patients with peripherl vascular disease. Curr. Med. Rex Opin. 1991; 12: 325, 3318. Castelluccio A., Bologna E. Effect of sulodexide on blood viscosity in patients with peripherl vascular disease. Curr. Med. Rex Opin. 1991; 12: 325, 331
   PubMed Web of Science ®Google Scholar
• Christie M., Delley A., Marbert G. A. Fibrinogen, Factor VIII related antigen, antithrombin III and alpha-2-antiplasmin in peripheral arterial disease. Thromb. Haemost. 1984; 52: 204, 2429. Christie M., Delley A., Marbert G. A. Fibrinogen, Factor VIII related antigen, antithrombin III and alpha-2-antiplasmin in peripheral arterial disease. Thromb. Haemost. 1984; 52: 204, 242
   Google Scholar
• Ciuffetti G., Mercuri M., Susta A., Lupattelli G., Pasqualini L., Lombardini R., Mannarino E. Effects of 3-glycosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study. Angiology 1989; 40: 255, 25910. Ciuffetti G., Mercuri M., Susta A., Lupattelli G., Pasqualini L., Lombardini R., Mannarino E. Effects of 3-glycosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study. Angiology 1989; 40: 255, 259
   PubMed Web of Science ®Google Scholar
• Coffman J. D. Vasodilator drugs in peripheral vascular disease. New Engl. J. Med. 1979; 300: 713, 71711. Coffman J. D. Vasodilator drugs in peripheral vascular disease. New Engl. J. Med. 1979; 300: 713, 717
   PubMed Web of Science ®Google Scholar
• Condorelli M., Chiariello M., Dagianti A., Penco M., Dalla Volta S., Pengo V., Schivazappa L., Mattioli G., Mattioli A.V., Brusoni B., Trotta E., Bignamini A. IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction. JACC 1994; 23: 27, 3412. Condorelli M., Chiariello M., Dagianti A., Penco M., Dalla Volta S., Pengo V., Schivazappa L., Mattioli G., Mattioli A.V., Brusoni B., Trotta E., Bignamini A. IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction. JACC 1994; 23: 27, 34
   Google Scholar
• Crepaldi G., Fellin R., Calabro A., Rossi A., Ventura A., Mannarino E., Senin U., Ciuffetti G., Descovich G. C., Gaddi A., Rimondi S., Pozza G., Vicari A., Carandente O., Mancini M., Rubba P., Postiglione A., Strano A., Avellone G., Davi G., Novo S., Pinto A., Capurso A., Resta F., Mogavero A.M., Bucci A., Antonini R., Lalloni L. Double blind multicentre trial on a new medium molecular weight glycos-aminoglycan. Current therapeutic effects and perspectives for clinical use. Atherosclerosis 1990; 81: 233, 24313. Crepaldi G., Fellin R., Calabro A., Rossi A., Ventura A., Mannarino E., Senin U., Ciuffetti G., Descovich G. C., Gaddi A., Rimondi S., Pozza G., Vicari A., Carandente O., Mancini M., Rubba P., Postiglione A., Strano A., Avellone G., Davi G., Novo S., Pinto A., Capurso A., Resta F., Mogavero A.M., Bucci A., Antonini R., Lalloni L. Double blind multicentre trial on a new medium molecular weight glycos-aminoglycan. Current therapeutic effects and perspectives for clinical use. Atherosclerosis 1990; 81: 233, 243
   PubMed Web of Science ®Google Scholar
• Crepaldi G., Rossi A., Coscetti G., Abruzzese E., Calveri U., Calabrò A. Sulodexide oral administration influences blood viscosity and fibrinolysis. Drugs Exptl Clin. Rex 1992; XVIII: 189–19514. Crepaldi G., Rossi A., Coscetti G., Abruzzese E., Calveri U., Calabrò A. Sulodexide oral administration influences blood viscosity and fibrinolysis. Drugs Exptl Clin. Rex 1992; XVIII: 189–195
   Google Scholar
• Crowder J. E., Cohn J. B., Savitsky J. P., Morgani D. A., Slywka J., Cobert B. L., Hryniewcki S., Piccirillo R. T., Wilcox C. S. Efficacy and safety of pentoxi-fylline in geriatric patients with intermittent claudication. Angiology 1989; 40: 795, 80215. Crowder J. E., Cohn J. B., Savitsky J. P., Morgani D. A., Slywka J., Cobert B. L., Hryniewcki S., Piccirillo R. T., Wilcox C. S. Efficacy and safety of pentoxi-fylline in geriatric patients with intermittent claudication. Angiology 1989; 40: 795, 802
   PubMed Web of Science ®Google Scholar
• Della Marchina M., Bellucci M., Palazzini E. Medium term oral sulodexide treatment of diabetic patients suffering from peripheral arterial obstructive disease: a double-blind, placebo-controlled study. Progr. Rep. 1992; 4: 5, 1516. Della Marchina M., Bellucci M., Palazzini E. Medium term oral sulodexide treatment of diabetic patients suffering from peripheral arterial obstructive disease: a double-blind, placebo-controlled study. Progr. Rep. 1992; 4: 5, 15
   Google Scholar
• Dettelbach H. R., Aviado D. M. Clinical pharmacology of pentoxifylline with special reference to its hemorheologic effect for the treatment of intermittent claudication. J. Clin. Pharmacol. 1985; 25: 8, 2617. Dettelbach H. R., Aviado D. M. Clinical pharmacology of pentoxifylline with special reference to its hemorheologic effect for the treatment of intermittent claudication. J. Clin. Pharmacol. 1985; 25: 8, 26
   PubMed Web of Science ®Google Scholar
• Dettori A. G., Manotti C., Quintavalla R., Portioli D. Effetti del sulodexide sul sistema emocoagulativo-fibrinolitico e sull'attività lipasemica nell'uomo. Atherosclerosis and Cardiovascular Diseases, S. Lenzi, G. C. Descovich. Editrice Compositori, Bologna 1984; 263–6918. Dettori A. G., Manotti C., Quintavalla R., Portioli D. Effetti del sulodexide sul sistema emocoagulativo-fibrinolitico e sull'attività lipasemica nell'uomo. Atherosclerosis and Cardiovascular Diseases, S. Lenzi, G. C. Descovich. Editrice Compositori, Bologna 1984; 263–69
   Google Scholar
• Di Perri T., Carandente O., Vittoria A., Guerrini M., Messa G. L. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease. Angiology 1984; 35: 427, 43519. Di Perri T., Carandente O., Vittoria A., Guerrini M., Messa G. L. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease. Angiology 1984; 35: 427, 435
   PubMed Web of Science ®Google Scholar
• Donaldson M. C., Matthew E. T., Hadjimichael J. Markers of thrombotic activity in arterial disease. Arch Surg 1987; 122: 897, 90020. Donaldson M. C., Matthew E. T., Hadjimichael J. Markers of thrombotic activity in arterial disease. Arch Surg 1987; 122: 897, 900
   PubMed Web of Science ®Google Scholar
• Fiore G., Baraldi A., Gambarotta G. C., Franco A., Liberati C. Inhibition of plasminogen activator inhibitor (PAI-I) by sulodexide in post-thrombophlebitis patients. J. Drug Develop. 1991; 3: 173, 17821. Fiore G., Baraldi A., Gambarotta G. C., Franco A., Liberati C. Inhibition of plasminogen activator inhibitor (PAI-I) by sulodexide in post-thrombophlebitis patients. J. Drug Develop. 1991; 3: 173, 178
   Google Scholar
• Hess H. Anticoagulant therapy of peripheral arterial thrombosis. Thromb. Diath. Haemorrhag. 1965; 371–376, Suppl. 2122. Hess H. Anticoagulant therapy of peripheral arterial thrombosis. Thromb. Diath. Haemorrhag. 1965; 371–376, Suppl. 21
   Google Scholar
• Liguori L., Saviano M., Lampugnani R., Spartera C., Bonavita E., Frasson P., Giungi R, Sbriccoli A., Catania G., Naldini G., Spina P., D'Addetta G., Cavassini G. B. Efficacy, tolerability and dose-effect relationship of oral sulodexide in obstructive peripheral arterial disorders. Adv. Ther. 1993; 10: 52, 6623. Liguori L., Saviano M., Lampugnani R., Spartera C., Bonavita E., Frasson P., Giungi R, Sbriccoli A., Catania G., Naldini G., Spina P., D'Addetta G., Cavassini G. B. Efficacy, tolerability and dose-effect relationship of oral sulodexide in obstructive peripheral arterial disorders. Adv. Ther. 1993; 10: 52, 66
   Web of Science ®Google Scholar
• Lunetta M., Salanitri T. Lowering of plasma viscosity by the oral administration of the glycosaminoglycan sulodexide in patients with peripheral vascular disease. J. Internat. Med. Res. 1992; 20: 45–5324. Lunetta M., Salanitri T. Lowering of plasma viscosity by the oral administration of the glycosaminoglycan sulodexide in patients with peripheral vascular disease. J. Internat. Med. Res. 1992; 20: 45–53
   PubMed Web of Science ®Google Scholar
• Mannarino E., Pasqualini L., Ciuffetti G., Lombardini R. Effect of oral administration of sulodexide on fibrinolysis and plasma viscosity. Drug Invest. 1992; 4: 346, 35025. Mannarino E., Pasqualini L., Ciuffetti G., Lombardini R. Effect of oral administration of sulodexide on fibrinolysis and plasma viscosity. Drug Invest. 1992; 4: 346, 350
   Web of Science ®Google Scholar
• Mauro M., Ferraro G., Palmieri G. Profibrinolytic and antithrombotic effects of sulodexide oral administration: a double-blind, crossover, placebo-controlled study. Curr. Ther. Res. 1992; 51: 342, 35026. Mauro M., Ferraro G., Palmieri G. Profibrinolytic and antithrombotic effects of sulodexide oral administration: a double-blind, crossover, placebo-controlled study. Curr. Ther. Res. 1992; 51: 342, 350
   Web of Science ®Google Scholar
• Messa G. L., La Placa G., Puccetti L., Acciavatti A., Provvedi T., Palazzini E., Di Perri T. Pharmacodynamic effects of sulodexide on profibrinolytic and haemor-rheological patterns. Clin. Drug Invest. 1995; 10: 165, 17127. Messa G. L., La Placa G., Puccetti L., Acciavatti A., Provvedi T., Palazzini E., Di Perri T. Pharmacodynamic effects of sulodexide on profibrinolytic and haemor-rheological patterns. Clin. Drug Invest. 1995; 10: 165, 171
   Web of Science ®Google Scholar
• Palazzini E., Procida C. Effect of some muchopolisaccharides on activated Factor X. Biochem. Pharmacol. 1978; 27: 608, 61028. Palazzini E., Procida C. Effect of some muchopolisaccharides on activated Factor X. Biochem. Pharmacol. 1978; 27: 608, 610
   PubMed Web of Science ®Google Scholar
• Palmieri G., Ambrosi G., Cantoni A., Agrati A., Palazzini E. Clinical evaluation of a native low molecular weight heparin in the management of symptomatic peripheral vasculopathy in the elderly. Curr. Ther. Res. 1987; 41: 998, 100929. Palmieri G., Ambrosi G., Cantoni A., Agrati A., Palazzini E. Clinical evaluation of a native low molecular weight heparin in the management of symptomatic peripheral vasculopathy in the elderly. Curr. Ther. Res. 1987; 41: 998, 1009
   Web of Science ®Google Scholar
• Palmieri G. C., Ambrosi G., Nazzari M., Palazzini E. The influence of sulodexide on some coagulation parameters: a pharmacokinetics study. Clot. Hemat. Malign. 1985; 2: 730. Palmieri G. C., Ambrosi G., Nazzari M., Palazzini E. The influence of sulodexide on some coagulation parameters: a pharmacokinetics study. Clot. Hemat. Malign. 1985; 2: 7
   Google Scholar
• Petruzzellis V., Quaranta D., Florio T. Sull'attivita terapeutica del sulodexide nelle arteriopatie obliteranti degli arti inferiori. Biol. Med. 1989; 11: 61, 7331. Petruzzellis V., Quaranta D., Florio T. Sull'attivita terapeutica del sulodexide nelle arteriopatie obliteranti degli arti inferiori. Biol. Med. 1989; 11: 61, 73
   Google Scholar
• Porter J. M., Cutler B. S., Lee B. Y., Reich T., Reichle F. A., Scogin J. T., Strandness D. E. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter, controlled, double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am. Heart J. 1982; 104: 66, 7232. Porter J. M., Cutler B. S., Lee B. Y., Reich T., Reichle F. A., Scogin J. T., Strandness D. E. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter, controlled, double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am. Heart J. 1982; 104: 66, 72
   PubMed Web of Science ®Google Scholar
• Romano F., Platania M., Costa A., Salanitri T., Palazzini E. The effect of sulodexide on blood viscosity in patients with peripheral vascular disease. Eur. J. Clin. Rex 1992; 3: 73, 8233. Romano F., Platania M., Costa A., Salanitri T., Palazzini E. The effect of sulodexide on blood viscosity in patients with peripheral vascular disease. Eur. J. Clin. Rex 1992; 3: 73, 82
   Google Scholar
• Saviano M., Maleti O., Liguori L. Double-blind, double-dummy, randomized, multi-centre clinical assessment of the efficacy, tolerability and dose-effect relationship of sulodexide in chronic venous insufficiency. Curr. Med. Res. Opin. 1992; 13: 96, 10834. Saviano M., Maleti O., Liguori L. Double-blind, double-dummy, randomized, multi-centre clinical assessment of the efficacy, tolerability and dose-effect relationship of sulodexide in chronic venous insufficiency. Curr. Med. Res. Opin. 1992; 13: 96, 108
   Web of Science ®Google Scholar
• Sola G., Valle I. II sulodexide nel trattamento delle arteriopatie periferiche croniche. Gazz. Med. It. -Arch. Sci. Med. 1986; 145: 91, 9635. Sola G., Valle I. II sulodexide nel trattamento delle arteriopatie periferiche croniche. Gazz. Med. It. -Arch. Sci. Med. 1986; 145: 91, 96
   Google Scholar
• Verstraete M. Current therapy for intermittent claudication. Drugs 1982; 24: 240, 24736. Verstraete M. Current therapy for intermittent claudication. Drugs 1982; 24: 240, 247
   PubMed Web of Science ®Google Scholar
• Zahavi J., Zahavi M. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. Thromb. Haemost. 1985; 53: 105, 10937. Zahavi J., Zahavi M. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. Thromb. Haemost. 1985; 53: 105, 109
   PubMed Web of Science ®Google Scholar